Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma

NCT01014507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hodgkins Lymphoma

Interventions

DRUG: 8 cycles BEACOPPesc plus oral contraceptive
DRUG: 8 cycles BEACOPPesc plus Goserelin

Sponsor

University of Cologne